Health Care Resource Use and Costs for Crohn’s Disease before and after Infliximab Therapy
oleh: Dustin E Loomes, Christopher Teshima, Philip Jacobs, Richard Fedorak
| Format: | Article |
|---|---|
| Diterbitkan: | Wiley 2011-01-01 |
Deskripsi
BACKGROUND: Infliximab therapy in patients with Crohn’s disease decreases resource use; however, the overall impact on health-related expenditures is unclear, especially beyond one year of study.